CN105461656A - Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine - Google Patents
Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine Download PDFInfo
- Publication number
- CN105461656A CN105461656A CN201510761975.0A CN201510761975A CN105461656A CN 105461656 A CN105461656 A CN 105461656A CN 201510761975 A CN201510761975 A CN 201510761975A CN 105461656 A CN105461656 A CN 105461656A
- Authority
- CN
- China
- Prior art keywords
- add
- aprotic solvent
- dissolved
- reaction
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Abstract
The present invention discloses a novel process for the preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine. The process uses o-halogenated benzenesulfonic acid and m-xylene as raw materials, which are subjected to dehydration condensation with methylsulfonic acid and phosphorus pentoxide as condensing agents to generate halogenated diarylsulfone. Halogenated diarylsulfone and piperazine are subjected to a substitution reaction in an aprotic solvent to produce piperazine ring substituted diarylsulfone; the piperazine ring substituted diarylsulfone is reduced by hexachlorodisilane in an aprotic solvent to obtain a product with high yield. This method has the advantages of cheap and easily available raw materials, avoidance of the usage of a noble metal catalyst and treatment of residual palladium, simple operation, mild reaction conditions, simple post-treatment, and potential application values.
Description
Technical field
The present invention relates to medicinal chemistry art, be specifically related to prepare the fertile novel process for Xi Ting.
Background technology
Fertile for western spit of fland chemistry 1-[2-(2 by name, 4-3,5-dimethylphenyl) sulfydryl] phenyl]-piperazine, it is serotonin transporter inhibitor, and Active Regulation is carried out to its acceptor, developed jointly by Ling Bei and military field, obtain U.S. FDA approval listing in September, 2013, trade(brand)name Brintellix, is clinically used for the treatment of major depressive disorder and breadth first algorithm.
Current Yuan Yan company discloses the preparation method (WO2007144005, CN101472906) of this compound, and this compound has three kinds of synthetic methods, and reaction scheme is as follows:
Method 1:
This reaction process has three steps, and wherein two-step reaction all uses palladium source, and cost is relatively high, is unsuitable for suitability for industrialized production.
Method 2:
Reaction process is one kettle way, and reaction process is fairly simple, but reaction process cannot effectively control, and a lot of side reaction may occur, the more difficult control of quality product
Method 3:
This reaction is two steps, although reaction process is fairly simple, operation is also relatively easy, reaction process uses palladium noble metal catalyst, is not suitable for suitability for industrialized production, and this patent has been authorized and entered, and need consider patent evasion.
Summary of the invention
In order to solve the problem existing for existing preparation method, the invention discloses the fertile novel process for Xi Ting of preparation, this method avoid use noble metal catalyst, raw material is cheap and easy to get, and reaction conditions is gentle, is beneficial to suitability for industrialized production.
Particular content is as follows:
Join in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, be heated to 100 ~ 120 DEG C of backflows, reflection is spent the night, bromothiophenol and N methyl piperazine generation halogenating reaction, after question response terminates, stops heating, is cooled to room temperature.Aftertreatment obtains intermediate 1.Wherein temperature of reaction preferably 120 DEG C.
Intermediate 1 and 2,4-dimethyl iodobenzene are joined in toluene solvant, under nitrogen protection, adds Pddba
2and rac-BINAP.Add NaOBu
t.Be heated to 100 ~ 120 DEG C of backflows, reaction is spent the night.After question response terminates, aftertreatment obtains intermediate 2.Wherein temperature of reaction preferably 100 DEG C.
Intermediate 2 is dissolved in aprotic solvent, adds a certain amount of phenyl chloroformate, stirring at room temperature 4-18h, after question response terminates.Be cooled to room temperature, add moisture and go out organic phase, aqueous phase toluene extracts three times, and merge organic phase and obtain oily matter, underpressure distillation obtains intermediate 3.Wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred tetrahydrofuran (THF).Phenyl chloroformate add-on is 1-3 times of intermediate 2 mole number.
Intermediate 3 is dissolved in aprotic solvent, adds salt of wormwood, stirring heating, reaction 1-24h, preferred reaction 8h; After question response terminates.Be cooled to room temperature, aftertreatment obtains fertile for Xi Ting.Wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred acetone.
Its technical process is as follows:
Concrete embodiment
Following example is to describe the present invention in detail, but should not be construed as limiting the invention.
Embodiment 1:
Bromothiophenol (4.7g, 25mmol) and N methyl piperazine (2.5g, 25mmol) are dissolved in 60ml toluene solvant, be heated to 120 DEG C, reaction is spent the night, bromothiophenol and N methyl piperazine generation halogenating reaction, after question response terminates, stop heating, be cooled to room temperature.Add 50ml water, filter to isolate aqueous phase, organic phase saturated aqueous common salt and clear water washing, merge aqueous phase toluene and extract.Removed under reduced pressure toluene, obtains intermediate 1, product 4.4g, yield 85%.
Embodiment 2:
By intermediate 1(4.2g, 20mmol) be dissolved in 40ml toluene, add 2,4-dimethyl iodobenzene (4.6g, 20mmol), add Pddba
2,rac-BINAP and NaOBu
t.Reflux to 100 DEG C, reaction is spent the night.After reaction terminates, stop heating, be cooled to room temperature.Add water, filter to isolate aqueous phase, organic phase salt solution and clear water washing, merge aqueous phase toluene and extract.Removed under reduced pressure toluene, obtains intermediate 2.Product 5.4g, yield 87%.
Embodiment 3:
By intermediate 2(3.1g, 10mmol) and phenyl chloroformate (1.6g, 10mmol) in, be dissolved in 30mL tetrahydrofuran (THF), stirring at room temperature 4h, after question response terminates.Be cooled to room temperature, reaction solution joins in 200mL water, stirred at ambient temperature 2 hours, filters, is washed to neutrality, dry product 3.8g, productive rate 91%.
Embodiment 4:
By intermediate 3(4.2g, 10mmol) be dissolved in acetone 20mL, add salt of wormwood, stirring heating, reaction 8h, after question response terminates.Be cooled to room temperature, reaction solution joins in 200mL water, stirred at ambient temperature 2 hours, filters, is washed to neutrality, obtains product 2.8g, yield 94%.
Claims (7)
1. prepare a fertile novel process for Xi Ting, its operational path is as follows:
(1) be dissolved in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, reacting by heating is spent the night, and after question response terminates, stop heating, be cooled to room temperature, aftertreatment obtains intermediate 1;
(2) intermediate 1 and 2,4-dimethyl iodobenzene are joined in toluene solvant, under nitrogen protection, add Pddba
2and rac-BINAP, add NaOBu
t, reflux, reaction is spent the night, and after question response terminates, aftertreatment obtains intermediate 2;
(3) intermediate 2 is dissolved in aprotic solvent, adds a certain amount of phenyl chloroformate, stirring at room temperature 4-18h, after question response terminates, be cooled to room temperature, add moisture and go out organic phase, aqueous phase toluene extracts three times, and merge organic phase and obtain oily matter, underpressure distillation obtains intermediate 3;
(4) be dissolved in aprotic solvent by intermediate 3, add salt of wormwood, stirring heating, reaction 1-24h, after question response terminates, is cooled to room temperature, and aftertreatment obtains fertile for Xi Ting.
2. method as claimed in claim 1, step (1) is characterized in that: join in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, is heated to 100 ~ 120 DEG C of backflows; Wherein preferable reaction temperature is 120 DEG C.
3. method as claimed in claim 1, step (2) is characterized in that: join in toluene solvant by intermediate 1 and 2,4-dimethyl iodobenzene, under nitrogen protection, add Pddba
2and rac-BINAP, add NaOBu
t, be heated to 100 ~ 120 DEG C of backflows; Wherein preferable reaction temperature is 100 DEG C.
4. method as claimed in claim 1, step (3) is characterized in that: be dissolved in aprotic solvent by intermediate 2, and wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred tetrahydrofuran (THF).
5. method as described in claim 1,4, is characterized in that, phenyl chloroformate add-on is 1-3 times of intermediate 2 mole number.
6. method as claimed in claim 1, step (4) is characterized in that: be dissolved in aprotic solvent by intermediate 3, and wherein aprotic solvent is selected from the one in acetone, tetrahydrofuran (THF) and dioxane, preferred acetone.
7. method as described in claim 1,6, is characterized in that the reaction times is 1-24h, preferred 8h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510761975.0A CN105461656A (en) | 2015-11-11 | 2015-11-11 | Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510761975.0A CN105461656A (en) | 2015-11-11 | 2015-11-11 | Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105461656A true CN105461656A (en) | 2016-04-06 |
Family
ID=55599873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510761975.0A Pending CN105461656A (en) | 2015-11-11 | 2015-11-11 | Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461656A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105622546A (en) * | 2016-01-07 | 2016-06-01 | 美吉斯制药(厦门)有限公司 | Preparation method for vortioxetine |
WO2017215636A1 (en) * | 2016-06-16 | 2017-12-21 | 广东东阳光药业有限公司 | Diaryl sulphide piperazine compound and preparation method and use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105541759A (en) * | 2016-01-07 | 2016-05-04 | 美吉斯制药(厦门)有限公司 | Novel method for preparing vortioxetine |
CN105622546A (en) * | 2016-01-07 | 2016-06-01 | 美吉斯制药(厦门)有限公司 | Preparation method for vortioxetine |
-
2015
- 2015-11-11 CN CN201510761975.0A patent/CN105461656A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105541759A (en) * | 2016-01-07 | 2016-05-04 | 美吉斯制药(厦门)有限公司 | Novel method for preparing vortioxetine |
CN105622546A (en) * | 2016-01-07 | 2016-06-01 | 美吉斯制药(厦门)有限公司 | Preparation method for vortioxetine |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105622546A (en) * | 2016-01-07 | 2016-06-01 | 美吉斯制药(厦门)有限公司 | Preparation method for vortioxetine |
CN105622546B (en) * | 2016-01-07 | 2020-08-28 | 万全万特制药(厦门)有限公司 | Preparation method of vortioxetine |
WO2017215636A1 (en) * | 2016-06-16 | 2017-12-21 | 广东东阳光药业有限公司 | Diaryl sulphide piperazine compound and preparation method and use thereof |
JP2019525900A (en) * | 2016-06-16 | 2019-09-12 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | Diarylthioether piperazine compounds, their preparation and use |
US10927089B2 (en) | 2016-06-16 | 2021-02-23 | Sunshine Lake Pharma Co., Ltd. | Diaryl thioether piperazine compounds, preparation methods and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011281421A1 (en) | Process for preparing aminobenzoylbenzofuran derivatives | |
CN103242197B (en) | Preparation method of ultraviolet absorbent intermediate etocrilene (ETO) | |
CN101798271B (en) | Method for preparing (+/-)-norepinephrine | |
CN104356092A (en) | Preparation method for vortioxetine | |
CN105461656A (en) | Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine | |
CN102827010B (en) | Novel beta-aminopropanoic acid synthesis technology | |
CN104725335A (en) | Preparation method of high-purity vortioxetine hydrobromide | |
CN110563735A (en) | Method for preparing florasulam | |
CN105566162A (en) | Rilpivirine midbody preparing technology | |
CN106065005B (en) | Preparation method of R- (+) -2- [4- (hydroxyphenoxy) ] propionate | |
CN105348220A (en) | Synthetic method for vortioxetine hydrobromide | |
CN103145796B (en) | Synthesis process of neotame | |
CN113264843A (en) | Synthetic method of 3-aminobicyclo [1.1.1] pentane-1-carboxylic ester derivative | |
KR101744046B1 (en) | Process for preparing an intermediate useful for the synthesis of silodosin | |
WO2020127887A1 (en) | Process for the preparation of an intermediate product of ivosidenib | |
CN108164423B (en) | Preparation method of naftifine hydrochloride | |
WO2016146049A1 (en) | Industrial preparation method of midazolam | |
CN109608344A (en) | A kind of preparation method of (R) -3- amino butanol | |
CN106278914B (en) | A kind of synthesis technique of increase production of amines | |
CN110878082B (en) | Gatifloxacin and its synthesis method | |
CN104109135A (en) | Preparation method of 1-[2-(2,4-dimethyl phenylsulfanyl)-phenyl]piperazine | |
KR101404616B1 (en) | Method for Preparation of γ-fluorinated ketone derivatives | |
CN110386936B (en) | Preparation method of 4-chloro-7H-pyrrolo [2,3-d ] pyrimidine | |
CN108911991B (en) | Method for producing 2,3, 4-trifluoroaniline by solvent-free catalytic hydrogenation method | |
Shen et al. | An efficient synthesis of enantiomerically pure trans-N1, N2-dimethylcyclohexane-1, 2-diamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160406 |
|
WD01 | Invention patent application deemed withdrawn after publication |